Validity of Glycated Hemoglobin in Screening and Diagnosing Type 2 Diabetes Mellitus in Chinese Subjects

Yun Yu,Xiao-Jun Ouyang,Qing-Lin Lou,Liu-Bao Gu,Yong-Zhen Mo,Gary T. Ko,Chun-Chung Chow,Wing-Yee So,Ronald Ma,Alice Kong,Nicola Brown,Jennifer Nan,Juliana Chan,Rong-Wen Bian
DOI: https://doi.org/10.3904/kjim.2012.27.1.41
2012-01-01
Abstract:Background/Aims: The application of glycated hemoglobin (HbA(1c)) for the diagnosis of diabetes is currently under extensive discussion. In this study, we explored the validity of using HbA(1c) as a screening and diagnostic test in Chinese subjects recruited in Nanjing, China.Methods: In total, 497 subjects (361 men and 136 women) with fasting plasma glucose (PG) >= 5.6 mmol/L were recruited to undergo the oral glucose tolerance test (OGTT) and HbA(1c) test. Plasma lipid, uric acid, and blood pressure were also measured.Results: Using a receiver operating characteristic curve, the optimal cutoff point of HbA(1c) related to diabetes diagnosed by the OGTT was 6.3%, with a sensitivity and specificity of 79.6% and 82.2%, respectively, and the area under the curve was 0.87 (95% confidence interval, 0.83 to 0.92). A HbA(1c) level of 6.5% had a sensitivity and specificity of 62.7% and 93.5%, respectively. When comparing the HbA(1c) >= 6.5% or OGTT methods for diagnosing diabetes, the former group had significantly higher HbA(1c) levels and lower levels of fasting and 2-hour PG than the latter group. No significant difference was observed in the other metabolism indexes between the two groups.Conclusions: Our results suggest that HbA(1c) >= 6.5% has reasonably good specificity for diagnosing diabetes in Chinese subjects, which is in concordance with the American Diabetes Association recommendations.
What problem does this paper attempt to address?